Skip to Content
Uncategorized

WHO Approves Smallpox Experiments

New Scientist is reporting that a World Health Organization committee has approved “in principal” experiments with live smallpox virus. The goal is to improve vaccines and drugs. Before any experiments proceed, the decision must be approved by the WHO’s member…
November 12, 2004

New Scientist is reporting that a World Health Organization committee has approved “in principal” experiments with live smallpox virus. The goal is to improve vaccines and drugs. Before any experiments proceed, the decision must be approved by the WHO’s member countries at an assembly in May 2005. In addition, each individual experiment would have to be reviewed by the same advisory committee and local biosafety authorities.

The WHO declared smallpox eradicated in 1980, and the only stockpiles were kept at the U.S. Centers for Disease Control and Prevention and at Vector, the Russian State Research Center for Virology. Any new smallpox outbreak would be due either to a lab accident or to a bioterror attack.

Other proposed experiments would insert smallpox genes into related viruses so that researchers could test drugs that target specific viral enzymes, helping to make sure a drug would work against the true smallpox enzyme. (Present treatment plans in case of an outbreak call for the use of antiviral drugs that have never been tested against smallpox.)

However, a leading expert has questioned the necessity of the tests. D.A. Henderson, who led the eradication drive and chairs the WHO’s committee on smallpox and related viruses, told New Scientist the research is “pointless.” His reasoning is pretty sound: any new drug or vaccine can’t be tested for efficacy in people, making them of dubious value. And, as Henderson points out, it’s unlikely anyone will spend the billions of dollars necessary to make and stockpile any of these new compounds. There’s a small chance the U.S. government could choose to spend that money. But if it does, it’s a clear case of stockpiling against a theoretical attack instead of spending money to help provide basic healthcare to millions of Americans in need.

Keep Reading

Most Popular

Death and Jeff Bezos
Death and Jeff Bezos

Meet Altos Labs, Silicon Valley’s latest wild bet on living forever

Funders of a deep-pocketed new "rejuvenation" startup are said to include Jeff Bezos and Yuri Milner.

tonga eruption
tonga eruption

Tonga’s volcano blast cut it off from the world. Here’s what it will take to get it reconnected.

The world is anxiously awaiting news from the island—but on top of the physical destruction, the eruption has disconnected it from the internet.

mouse engineered to grow human hair
mouse engineered to grow human hair

Going bald? Lab-grown hair cells could be on the way

These biotech companies are reprogramming cells to treat baldness, but it’s still early days.

conceptual illustration showing various women's faces being scanned
conceptual illustration showing various women's faces being scanned

A horrifying new AI app swaps women into porn videos with a click

Deepfake researchers have long feared the day this would arrive.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.